Search Results - "Mehany, Ahmed B M"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

    Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives by Bakr, Rania B, Mehany, Ahmed B M, Abdellatif, Khaled R A

    Published in Anti-cancer agents in medicinal chemistry (01-01-2017)
    “…as EGFR inhibitors, mammalian target of rapamycin (mTOR) inhibitors, Src or dual Src/Abl inhibitors, glycogen synthase kinase-3b (GSK-3b) inhibitors or cyclin…”
    Get more information
    Journal Article
  6. 6

    Discovery of new quinolines as potent colchicine binding site inhibitors: design, synthesis, docking studies, and anti-proliferative evaluation by Hagras, Mohamed, El Deeb, Moshira A., Elzahabi, Heba S. A., Elkaeed, Eslam B., Mehany, Ahmed B. M., Eissa, Ibrahim H.

    “…Discovering of new anticancer agents with potential activity against tubulin polymerisation is still a promising approach. Colchicine binding site inhibitors…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Cetuximab Conjugated with Octreotide and Entrapped Calcium Alginate-beads for Targeting Somatostatin Receptors by Abdellatif, Ahmed A. H., Ibrahim, Mohamed A., Amin, Mohammed A., Maswadeh, Hamzah, Alwehaibi, Muhammed N., Al-Harbi, Sultan N., Alharbi, Zayed A., Mohammed, Hamdoon A., Mehany, Ahmed B. M., Saleem, Imran

    Published in Scientific reports (13-03-2020)
    “…There is a need to formulate oral cetuximab (CTX) for targeting colorectal cancer, which is reported to express somatostatin receptors (SSTRs). Therefore,…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Screening a Panel of Topical Ophthalmic Medications against MMP-2 and MMP-9 to Investigate Their Potential in Keratoconus Management by Belal, Amany, Elanany, Mohamed A, Santali, Eman Y, Al-Karmalawy, Ahmed A, Aboelez, Moustafa O, Amin, Ali H, Abdellattif, Magda H, Mehany, Ahmed B M, Elkady, Hazem

    Published in Molecules (Basel, Switzerland) (02-06-2022)
    “…Keratoconus (KC) is a serious disease that can affect people of any race or nationality, although the exact etiology and pathogenic mechanism are still…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Design and Synthesis of New Quinoxaline Derivatives as Potential Histone Deacetylase Inhibitors Targeting Hepatocellular Carcinoma: In Silico , In Vitro , and SAR Studies by Ma, Chao, Taghour, Mohammed S, Belal, Amany, Mehany, Ahmed B M, Mostafa, Naglaa, Nabeeh, Ahmed, Eissa, Ibrahim H, Al-Karmalawy, Ahmed A

    Published in Frontiers in chemistry (22-09-2021)
    “…Guided by the structural optimization principle and the promising anticancer effect of the quinoxaline nucleus, a new series of novel HDAC inhibitors were…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    Design, synthesis, docking study and anticancer evaluation of new trimethoxyphenyl pyridine derivatives as tubulin inhibitors and apoptosis inducers by Hagras, Mohamed, Mandour, Asmaa A, Mohamed, Esraa A, Elkaeed, Eslam B, Gobaara, Ibrahim M. M, Mehany, Ahmed B. M, Ismail, Nasser S. M, Refaat, Hanan M

    Published in RSC advances (13-12-2021)
    “…Microtubules have become an appealing target for anticancer drug development including mainly colchicine binding site inhibitors (CBSIs). A new series of novel…”
    Get full text
    Journal Article
  20. 20